Signaling Pathways - Sphingosine kinases (SphKs) - IRG-1R - DOT1L - P-glycoprotein (P-gp)
清除全部
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb(P糖蛋白)抑制剂
- A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂
- A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂
- A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂
- A8208 Tariquidar2 Citation中文名: 他立喹达Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂